Opal Oncology Overview
- Year Founded
-
2012
- Status
-
Private
- Latest Deal Type
-
Seed
- Latest Deal Amount
-
$1.3M
- Investors
-
3
Opal Oncology General Information
Description
Developer of brain cancer therapies designed to provide treatment for incurable brain cancer. The company's therapies are primarily focused on killing a range of brain cancer cell lines over other treatments holding out the possibility of increasing life expectancy, enabling healthcare sectors to deliver proper treatment for brain cancer.
Contact Information
Website
www.opalonc.com
Formerly Known As
Opal Oncology Limited
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Primary Office
- 23, Cambridge Science Park
- Cambridge CB4 0EY
- England, United Kingdom
Opal Oncology Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Seed Round | 08-Sep-2015 | $1.3M | 00.00 | 00.000 | Completed | Generating Revenue |
| 2. Seed Round | 01-May-2014 | Completed | Startup | |||
| 1. Grant | 02-Aug-2012 | Completed | Startup |
Opal Oncology Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Ordinary | 00,000 | 000.00 | 000.00 | 00 | 000.00 | 00.00 | ||
| Ordinary | 000 | 000.00 | 000.00 | 00 | 000.00 | 0.000 |
Opal Oncology Patents
Opal Oncology Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| GB-201805386-D0 | Pharmaeutical compounds | Inactive | 31-Mar-2018 | 0000000000 |
Opal Oncology Executive Team (2)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Sunil Shah | Chief Executive Officer & Chairman | ||
| Andrew David Morley | Chief Scientific Officer |
Opal Oncology Board Members (2)
| Name | Representing | Role | Since |
|---|---|---|---|
| Christopher Torrance Ph.D | Self | Board Member | 000 0000 |
| Sunil Shah | Self | Chief Executive Officer & Chairman | 000 0000 |
Opal Oncology Investors (3)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| O2h Ventures | Venture Capital | Minority | 000 0000 | 000000 0 | |
| Innovate UK | Government | 000 0000 | 000000 0 | ||
| Medical Research Council | VC-Backed Company | 000 0000 | 000000 0 |